Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / articles / LLY - LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen Eli Lilly | Benzinga

LLY - LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen Eli Lilly | Benzinga

Eli Lilly and Company

Hampus Hillerstrom, CEO of the Down syndrome research organization LuMind IDSC, is advocating for access to Alzheimer's drugs made by Eisai Co Ltd (OTC: ESALY)/ Biogen Inc's (NASDAQ: BIIB) and Eli Lilly And Co's (NYSE: LLY). The former biotech executive is also hoping to include people with Down syndrome in Alzheimer's trials.

According to Reuters, Hillerstrom is at odds with neurologists who recommend against immediate use, citing how Alzheimer's drugs ...

Full story available on Benzinga.com
Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...